Literature DB >> 12050329

Stunning of iodide transport by (131)I irradiation in cultured thyroid epithelial cells.

Per Postgård1, Jakob Himmelman, Ulrika Lindencrona, Nirmal Bhogal, Dennis Wiberg, Gertrud Berg, Svante Jansson, Ernst Nyström, Eva Forssell-Aronsson, Mikael Nilsson.   

Abstract

UNLABELLED: The existence of thyroid stunning (i.e., inhibited thyroidal iodide uptake after administration of diagnostic amounts of (131)I) is controversial and is currently a subject of debate. To our knowledge, the stunning phenomenon has not been investigated previously in vitro.
METHODS: Growth-arrested porcine thyroid cells that formed a tight and polarized monolayer in a bicameral chamber were irradiated with 3-80 Gy (131)I present in the surrounding culture medium for 48 h. The iodide transport capacity after irradiation was evaluated 3 d later by measuring the transepithelial (basal to apical) flux of trace amounts of (125)I.
RESULTS: The basal-to-apical (125)I transport decreased with increasing absorbed dose acquired from (131)I; a nearly 50% reduction was observed already at 3 Gy. Stable iodide at the same molarity as (131)I (10(-8) mol/L) had no effect on the (125)I transport. Cell number and epithelial integrity were not affected by irradiation.
CONCLUSION: Stunning of iodide transport is detected after (131)I irradiation of cultured thyroid cells. The degree of inhibition of transport is dependent on the absorbed dose.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12050329

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

1.  Do we read carefully?

Authors:  Mario Medvedec
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-09       Impact factor: 9.236

2.  Decreased radioiodine uptake of FRTL-5 cells after (131)I incubation in vitro: molecular biological investigations indicate a cell cycle-dependent pathway.

Authors:  Birgit Meller; Erzsébet Gaspar; Wibke Deisting; Barbara Czarnocka; Manfred Baehre; Björn E Wenzel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-29       Impact factor: 9.236

3.  Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseases.

Authors:  C Happel; W T Kranert; D Gröner; B Bockisch; A Sabet; I Vardarli; R Görges; K Herrmann; F Grünwald
Journal:  Endocrine       Date:  2020-03-16       Impact factor: 3.633

4.  Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases.

Authors:  Christian Happel; Wolfgang Tilman Kranert; Hanns Ackermann; Ina Binse; Benjamin Bockisch; Daniel Gröner; Ken Herrmann; Frank Grünwald
Journal:  Endocrine       Date:  2018-12-31       Impact factor: 3.633

5.  Presence of free triiodothyronine and free thyroxine in thyroid follicles may be correlated with the quick secretion of thyroid hormones under certain physiological conditions.

Authors:  Haihong Shi; Wanrong Lin; B O Liang; Huiyao Cai; Qingyan Cai; Yaxiong Shi; Huibin Huang
Journal:  Biomed Rep       Date:  2016-02-10

6.  The Effect of Diagnostic Absorbed Doses from 131I on Human Thyrocytes in Vitro.

Authors:  Zbigniew Adamczewski; Mariusz Stasiołek; Bolesław Karwowski; Marek Dedecjus; Daria Orszulak-Michalak; Anna Merecz; Przemysław W Śliwka; Bartosz Puła; Andrzej Lewiński
Journal:  Int J Mol Sci       Date:  2015-06-29       Impact factor: 5.923

7.  Statistical and radiobiological analysis of the so-called thyroid stunning.

Authors:  Stephan Walrand; Michel Hesse; François Jamar
Journal:  EJNMMI Res       Date:  2015-11-19       Impact factor: 3.138

8.  ⁹⁹mTcO₄--, auger-mediated thyroid stunning: dosimetric requirements and associated molecular events.

Authors:  Béatrice Cambien; Philippe R Franken; Audrey Lamit; Thibault Mauxion; Peggy Richard-Fiardo; Julien Guglielmi; Lydie Crescence; Bernard Mari; Thierry Pourcher; Jacques Darcourt; Manuel Bardiès; Georges Vassaux
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

9.  Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle models.

Authors:  Anders Josefsson; Eva Forssell-Aronsson
Journal:  EJNMMI Res       Date:  2014-06-11       Impact factor: 3.138

10.  A Clinical Trial of Optimal Time Interval Between Ablation and Diagnostic Activity When a Pretherapy RAI Scanning Is Performed on Patients With Differentiated Thyroid Carcinoma.

Authors:  Yafu Yin; Qiufen Mao; Song Chen; Na Li; Xuena Li; Yaming Li
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.